The Optic Neuritis Treatment Trial (ONTT) was a landmark randomized clinical trial showing that treatment with corticosteroids does not improve long-term visual outcomes for patients with acute demyelinating typical optic neuritis but may hasten visual recovery in the first 2 weeks.
1-3 Given the lack of a robust treatment effect with corticosteroids, the ONTT Study Group and clinical practice guidelines called for shared decision-making between patients and physicians when deciding whether to use corticosteroids for acute neuritis.
4 Since the publication of the ONTT findings, the diagnosis of typical optic neuritis remains unchanged, and no additional short-term treatments have emerged. Therefore, the ONTT provides the only actionable data to date for counseling patients on the benefits of corticosteroids.